Table 2.

Mapping characteristics of samples assayed including the two biological replicates by treatment: control healthy “GF305” peach seedlings (A); PPV-infected “GF305” seedlings showing severe sharka symptoms (B); “GF305” peach seedlings grafted with healthy “Garrigues” (clonal) (C); PPV-infected “GF305” seedlings showing sharka symptoms grafted with healthy “Garrigues” (clonal) (D); healthy “GF305” peach seedlings grafted with healthy “Garrigues” (clonal) which were later inoculated with PPV at the end of the first cycle of evaluation (E). In addition, “Garrigues” almond samples grafted onto healthy (F) and inoculated “GF305” (G) rootstocks were included in the study. In bold type: the sequenced plant material, GF305 = peach; Garrigues = almond. With an inverted comma (’) = single forward; double inverted comma (”) = single reverse.

Treatments	Sample	Total Reads	Clean Reads	Reads Mapped P. persica v 2.0	Reads Mapped PPV Genome
GF305 Control	A (A’+A”)	151,699,038	151,376,821	123,331,659 (81.5%)	15 (0.00001%)
GF305  + PPV	B (B’+B”)	159,272,116	158,812,159	125,187,942 (78.8%)	2,071,915 (1.30%)
GF305  Control + Garrigues	C (C’+C”)	142,956,238	142,296,978	113,078,192 (79.5%)	152 (0.0001%)
GF305  + PPV + Garrigues	D (D’+D”)	143,511,454	143,041,550	109,499,620 (76.6%)	80,703 (0.06%)
GF305  Control + Garrigues + PPV	E (E’+E”)	148,551,466	148,233,453	114,097,915 (77.0%)	1904 (0.0013%)
GF305 Control + Garrigues	F (F’+F”)	140,514,568	140,158,744	88,206,273 (62.9%)	44 (0.00003%)
GF305 + PPV + Garrigues	G (G’+G”)	138,038,412	137,569,619	101,163,774 (73.5%)	45 (0.00003%)